WELLS FARGO & COMPANY/MN - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 51 filers reported holding CYTOSORBENTS CORP in Q2 2024. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q2 2024$319
-57.9%
453
-43.1%
0.00%
Q1 2024$757
+26.0%
796
+47.1%
0.00%
Q4 2023$601
-39.1%
541
+3.0%
0.00%
Q3 2023$987
-48.9%
525
-2.4%
0.00%
Q2 2023$1,932
+9.2%
538
+2.5%
0.00%
Q1 2023$1,770
+119.3%
525
+1.0%
0.00%
Q4 2022$807
-86.6%
520
-88.5%
0.00%
Q3 2022$6,000
-40.0%
4,513
-0.8%
0.00%
Q2 2022$10,000
-83.1%
4,551
-75.1%
0.00%
Q1 2022$59,000
-57.6%
18,241
-44.8%
0.00%
Q4 2021$139,000
+82.9%
33,020
+253.0%
0.00%
Q3 2021$76,000
+7.0%
9,354
+0.7%
0.00%
Q2 2021$71,000
-92.1%
9,292
-91.1%
0.00%
Q1 2021$903,000
+8.1%
104,123
-0.6%
0.00%
Q4 2020$835,000
+1.5%
104,759
+1.5%
0.00%
Q3 2020$823,000
-11.1%
103,179
+10.2%
0.00%
Q2 2020$926,000
+256.2%
93,622
+178.0%
0.00%
Q1 2020$260,000
+185.7%
33,682
+43.3%
0.00%
Q4 2019$91,000
-31.1%
23,510
-9.9%
0.00%
Q3 2019$132,000
-21.0%
26,093
+3.5%
0.00%
Q2 2019$167,000
-63.3%
25,213
-58.0%
0.00%
Q1 2019$455,000
+0.7%
60,096
+7.4%
0.00%
Q4 2018$452,000
-13.4%
55,942
+38.0%
0.00%
Q3 2018$522,000
-20.9%
40,533
-30.0%
0.00%
Q2 2018$660,000
+349.0%
57,897
+177.7%
0.00%
Q1 2018$147,000
+8.1%
20,849
-0.4%
0.00%
Q4 2017$136,000
+195.7%
20,929
+182.3%
0.00%
Q3 2017$46,000
+475.0%
7,414
+394.3%
0.00%
Q4 2016$8,000
+60.0%
1,500
+18.8%
0.00%
Q1 2016$5,000
-91.2%
1,263
-87.8%
0.00%
Q4 2015$57,000
+5600.0%
10,317
+8497.5%
0.00%
Q2 2015$1,000
-91.7%
120
-86.8%
0.00%
Q1 2015$12,0009120.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q2 2024
NameSharesValueWeighting ↓
Skylands Capital, LLC 1,126,300$8,706,0001.93%
Sargent Investment Group, LLC 471,755$3,647,0001.68%
Manatuck Hill Partners, LLC 125,000$966,0000.89%
Soleus Capital Management, L.P. 69,600$538,0000.63%
EAM Investors, LLC 136,098$1,052,0000.33%
Granahan Investment Management 691,130$5,342,0000.29%
EAM Global Investors LLC 61,795$478,0000.28%
Winning Points Advisors, LLC 35,000$269,0000.26%
Leap Investments LP 14,200$110,0000.16%
Avenir Corp 150,600$1,164,0000.16%
View complete list of CYTOSORBENTS CORP shareholders